top
Search terms
Results 1 - 3 of 3 - ordered by :
Escardio

Median follow-up was 60 months and the primary endpoint was time to first occurrence of a composite of cardiovascular death, myocardial infarction (MI), stroke, unstable angina and transient ...

Date : 27/08/2018
Escardio

AUGUSTUS was a prospective, multicenter, two-by-two factorial, randomized clinical trial, supported by the pharmaceutic industry, including 4614 patients with atrial fibrillation who had a recent ...

Date : 06/05/2019
Escardio

EMBARGO : 1 Septembre 2015 at 08:00 BST The Hot Line study, presented at ESC Congress 2015, and published simultaneously in the New England Journal of Medicine, “provides practice-changing ...

Date : 01/09/2015